De novo CDH1 mutation in a family presenting with early-onset diffuse gastric cancer

Clinical Genetics

Volumn 82, Issue 3, 2012, Pages 283-287

  Shah, Ma ^a   Salo Mullen, E ^b   Stadler, Z ^a,b   Ruggeri, Jm ^b   Mirander, M ^a   Pristyazhnyuk, Y ^a   Zhang, L ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

CDH1; Diffuse gastric cancer; E cadherin; Early onset; Hereditary

Indexed keywords

UVOMORULIN;

ADULT; AGED; ARTICLE; CASE REPORT; FAMILY HISTORY; FEMALE; GASTRECTOMY; GENE MUTATION; GENE SEQUENCE; GERMLINE MUTATION; HEREDITARY DIFFUSE GASTRIC CANCER; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER;

ADULT; AGE OF ONSET; AGED; CADHERINS; FAMILY; FEMALE; GERM-LINE MUTATION; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; STOMACH NEOPLASMS;

EID: 84865087395     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2011.01744.x     Document Type: Article

References (24)

1. Caldas C, Carneiro F, Lynch HT, Yokota J, Wiesner GL, Powell SM et al. Familial gastric cancer: overview and guidelines for management. J Med Genet 1999: 36: 873-880.
2. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P et al. E-cadherin germline mutations in familial gastric cancer. Nature 1998: 392: 402-405.
3. Humar B, Guilford P. Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci 2009: 100: 1151-1157.
4. Lynch HT, Grady W, Suriano G, Huntsman D. Gastric cancer: new genetic developments. J Surg Oncol 2005: 90: 114-133.
5. Oliveira C, Seruca R, Carneiro F. Genetics, pathology and clinics of familial gastric cancer. Int J Surg Pathol 2006: 14: 21-33.
6. Pharoah PD, Guilford P, Caldas C. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology 2001: 121: 1348-1353.
7. Kaurah P, MacMillan A, Boyd N, Senz J, De Luca A, Chun N et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA 2007: 297: 2360-2372.
8. Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet 2010: 47: 436-444.
9. Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, Hayashi A, Monaghan KG et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 2001: 344: 1904-1909.
10. Shaw D, Blair V, Framp A, Harawira P, McLeod M, Guilford P et al. Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut 2005: 54: 461-468.
11. Brooks-Wilson AR, Kaurah P, Suriano G, Leach SD, Senz J, Grehan N et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet 2004: 41: 508-517.
12. Oliveira C, Senz J, Kaurah P, Pinheiro H, Sanges R, Haegert A et al. Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet 2009: 18: 1545-1555.
13. Guilford P, Humar B, Blair V. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice. Gastric Cancer 2010: 13: 1-10.
14. Gayther SA, Gorringe KL, Ramus SJ, Huntsman D, Roviello F, Grehan N et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer Res 1998: 58: 4086-4089.
15. Humar B, Toro T, Graziano F, Muller H, Dobbie Z, Kwang-Yang H et al. Novel germline CDH1 mutations in hereditary diffuse gastric cancer families. Hum Mutat 2002: 19: 518-525.
16. Rodriguez-Sanjuan JC, Fontalba A, Mayorga M, Bordin MC, Hyland SJ, Trugeda S et al. A novel mutation in the E-cadherin gene in the first family with hereditary diffuse gastric cancer reported in Spain. Eur J Surg Oncol 2006: 32: 1110-1113.
17. Varady E, Deak B, Molnar ZS, Rosta A, Schneider T, Esik O. Second malignancies after treatment for Hodgkin's disease. Leuk Lymphoma 2001: 42: 1275-1281.
18. Ng AK, Kenney LB, Gilbert ES, Travis LB. Secondary malignancies across the age spectrum. Semin Radiat Oncol 2010: 20: 67-78.
19. Aypar U, Morgan WF, Baulch JE. Radiation-induced epigenetic alterations after low and high LET irradiations. Mutat Res 2010: 707: 24-33.
20. Oliveira C, Sousa S, Pinheiro H, Karam R, Bordeira-Carrico R, Senz J et al. Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. Gastroenterology 2009: 136: 2137-2148.
21. Li FP, Fraumeni JF Jr, Mulvihill JJ et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988: 48: 5358-5362.
22. Gonzalez KD, Buzin CH, Nolter KA, Gu D, Li W, Malkin D et al. High frequency of de novo mutations in Li-Fraumeni syndrome. J Med Genet 2009: 46: 689-693.
23. Corso G, Pedrazzani C, Pinheiro H, Fernandes E, Marrelli D, Rinnovati C et al. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer 2011: 47: 631-639.
24. Bacani JT, Soares M, Zwingerman R, di Nicola N, Senz J, Riddell R et al. CDH1/E-cadherin germline mutations in early-onset gastric cancer. J Med Genet 2006: 43: 867-872.